Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11PET/CT – an optimised imaging protocol

Autor: Alberts, I, Hünermund, JN, Sachpekidis, C, Zacho, HD, Mingels, C, Bohn, KP, Läppchen, T, Gourni, E, Rominger, A, Afshar-Oromieh, A

Publikováno v: Nuklearmedizin. Nuclear medicine; April 2021, Vol. 60 Issue: 2

Autor: Raade AU; Nuklearmedicinsk Afdeling, Odense Universitetshospital., Buch-Olsen KM; Nuklearmedicinsk Afdeling, Odense Universitetshospital.; Klinisk Institut, Syddansk Universitet., Lund L; Klinisk Institut, Syddansk Universitet.; Urologisk Afdeling, Odense Universitetshospital., Zacho HD; Nuklearmedicinsk Afdeling, Klinisk Kræftforskningscenter, Aalborg Universitetshospital.; Klinisk Institut, Aalborg Universitet., Borre M; Urinvejskirurgi, Aarhus Universitetshospital.; Institut for Klinisk Medicin, Aarhus Universitet., Holm J; Nuklearmedicinsk Afdeling, Odense Universitetshospital.; Klinisk Institut, Syddansk Universitet., Pedersen KT; Nuklearmedicinsk Afdeling, Odense Universitetshospital., Hildebrandt MB; Nuklearmedicinsk Afdeling, Odense Universitetshospital.; Klinisk Institut, Syddansk Universitet.

Publikováno v: Ugeskrift for laeger [Ugeskr Laeger] 2024 Aug 12; Vol. 186 (33).

How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers.

Autor: Bentestuen M; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: m.bentestuen@rn.dk., Nalliah S; Department of Radiology, Aalborg University Hospital, Aalborg, Denmark., Stolberg MMK; Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Publikováno v: Seminars in nuclear medicine [Semin Nucl Med] 2024 May; Vol. 54 (3), pp. 345-355. Date of Electronic Publication: 2023 Dec 04.

Presurgical ⁶⁸ Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.

Autor: Djaïleb L; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: ldjaileb@chu-grenoble.fr., Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; ULCA-Caltech Medical Scientist Training Program, David Geffen School of Medicine, Los Angeles, CA, USA., Thompson D; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Farolfi A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rajagopal A; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Grogan TR; Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, CA, USA., Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Benz MR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, USA., Hotta M; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Barbato F; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Schwarzenböck SM; Department of Nuclear Medicine, University Medical Centre, Rostock, Germany., Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark., Juarez R; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Cooperberg M; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Carroll P; Department of Urology, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Washington S; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Reiter RE; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Eiber M; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.

Publikováno v: European urology [Eur Urol] 2023 Dec; Vol. 84 (6), pp. 588-596. Date of Electronic Publication: 2023 Jul 21.

FAPI-avid nonmalignant PET/CT findings: An expedited systematic review.

Autor: Bentestuen M; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, North Jutland Region, Denmark. Electronic address: m.bentestuen@rn.dk., Al-Obaydi N; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, North Jutland Region, Denmark., Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, North Jutland Region, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, North Jutland Region, Denmark.

Publikováno v: Seminars in nuclear medicine [Semin Nucl Med] 2023 Sep; Vol. 53 (5), pp. 694-705. Date of Electronic Publication: 2023 Feb 20.